UK/Europe

UK’s National Health Service Report Addresses Barriers to Medical Cannabis

The report indicates that the National Institute for Health Research should prioritize research on cannabis-based products in five areas, including chronic pain in children and young people.

New York

Here’s How New York’s Cannabis Companies Lobbied in the Legislature’s Final Days

Curaleaf lobbied on more state bills than any other cannabis company as the session came to a close.

Global

The Complicated Backstory of Europe’s First Cannabis Import from Latin America

Possible winners? Workers in Uruguay and Colombia, and patients in Europe. Possible losers? Adult use consumers in Uruguay, who face a shortage.

Global

Australian Government Moves to Bolster Medical Cannabis Industry

The administration announced priority licensing for large-scale business projects to ramp up economic growth in the country.

Louisiana

Louisiana’s Medical Cannabis Program Finally Goes Live

Four years after the law opened the gates, the first tinctures will hit pharmacies Tuesday. It’s been a long journey.

Global

El Salvador Inches Toward Legal Medical Cannabis

But the conservative politician pushing the measure says that’s as far as it goes.

Lobbying

Canopy Growth’s Expanding Lobbying Footprint in the United States

Cannabis Wire has learned that the global company is now lobbying in at least three states.

Global

St. Kitts and Nevis Takes a Big Step Toward Cannabis Reform

In the wake of a major report on all aspects of cannabis policy, the prime minister moves to relax the rules.

Hemp, New York

Canopy Growth Unveils New York Hemp Industrial Park

NY’s Southern Tier is “well on its way to becoming the Silicon Valley of industrial hemp,” Sen. Chuck Schumer said Monday.